Advertisement

Topics

BMS gains right of first refusal on IFM Therapeutics LLC's anti-inflammatory program

15:41 EDT 7 Aug 2017 | Elsevier Business Intelligence

IFM Therapeutics LLC granted Bristol-Myers Squibb Co. a right of first refusal on its preclinical NLR protein 3 (NLRP3) antag...

Original Article: BMS gains right of first refusal on IFM Therapeutics LLC's anti-inflammatory program

NEXT ARTICLE

More From BioPortfolio on "BMS gains right of first refusal on IFM Therapeutics LLC's anti-inflammatory program"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...